Results 71 to 80 of about 15,778 (214)
Síndrome de moyamoya associada a neurofibromatose tipo I em paciente pediátrico [PDF]
, 2011 CONTEXT: Neurofibromatosis type 1 (NF-1) is the most prevalent autosomal dominant genetic disorder among humans. Moyamoya disease is a cerebral vasculopathy that is only rarely observed in association with NF-1, particularly in the pediatric age range ...
DARRIGO JÚNIOR, Luiz Guilherme +5 more
core +1 more source
CNS Neuroscience &Therapeutics, Volume 32, Issue 3, March 2026.Synchronous arbitrary‐gate spectral Doppler (SAGSD) enables real‐time multi‐site hemodynamic monitoring during moyamoya disease revascularization. The novel “mountain” sign, defined as three or more velocity peaks within one cardiac cycle across multiple subcortical sites, was detected in 5 of 6 patients who developed cerebral hyperperfusion syndrome ...
Xiandi Zhang +13 more
wiley +1 more source
Journal of International Medical Research, 2022 Aneurysmal bone cyst is a type of benign bone pathology with expansile and osteolytic features whose etiology remains unclear. Graves’ disease is an autoimmune disease characterized by diffuse goiter and hyperthyroidism. Moyamoya disease is a progressive
Cai Gao-Rui +2 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Although antiplatelet agents are frequently prescribed in moyamoya disease in routine clinical practice, there are no large‐scale epidemiologic trials or randomized trial evidence to support their use in patients with moyamoya disease. Methods
Woo‐Keun Seo +7 more
doaj +1 more source
Stroke burden and functional impacts in adults with sickle cell disease
British Journal of Haematology, Volume 208, Issue 3, Page 1063-1073, March 2026.Stroke was identified in 4.6% of 454 adults with sickle cell disease. Stroke occurred not only across HbSS/Sβ0 phenotypes but also HbSC/Sβ+ as well, challenging traditional assumptions. Stroke was associated with long‐term functional impairment, including cognitive deficits and higher disability scores.
Jonathan St‐Onge +12 more
wiley +1 more source
Bioengineering, 2023 Moyamoya disease is a cerebrovascular disorder which causes a decrease in the cerebral blood flow rate. In this study, a lumped parameter model describing the pressures and flow rates in the heart chambers, circulatory system, and cerebral circulation ...
Surhan Bozkurt, Selim Bozkurt
doaj +1 more source
Clinical history and management recommendations of the smooth muscle dysfunction syndrome due to ACTA2 arginine 179 alterations [PDF]
, 2018 Smooth muscle dysfunction syndrome (SMDS) due to heterozygous ACTA2 arginine 179 alterations is characterized by patent ductus arteriosus, vasculopathy (aneurysm and occlusive lesions), pulmonary arterial hypertension, and other complications in smooth ...
A Kikuchi +55 more
core +3 more sources
APOE4 and cognition in intracranial atherosclerosis: beyond Alzheimer's pathology
Alzheimer's &Dementia, Volume 22, Issue 2, February 2026.Abstract INTRODUCTION The apolipoprotein E ε4 (APOE ε4) allele is a major genetic risk factor for Alzheimer's disease, but its relevance to cognition in intracranial atherosclerosis (ICAS) remains unclear. We investigated the association between APOE ε4 and cognition in ICAS. METHODS Baseline data from a multicenter cohort were analyzed.
Anqi Cheng +14 more
wiley +1 more source
The ‘Ivy Sign’ of Moyamoya disease
Asian Journal of Medical Sciences, 2019 Stroke is uncommon in pediatric age group. Moyamoya is a rare idiopathic disease characterized by progressive vaso-occlusion of the main blood vessels to the brain.
Ummer Karadan +1 more
doaj +1 more source